Form 4: Lemaitre Vascular Inc. CFO Awarded Stock Options and Restricted Stock Units

Lemaitre Vascular Inc.'s Chief Financial Officer, Joseph P. Pellegrino Jr., received stock options and restricted stock units as part of his compensation package.

Summary

• Joseph P. Pellegrino Jr., the Chief Financial Officer of Lemaitre Vascular Inc., was granted stock options and restricted stock units on December 6, 2024.
• The stock options allow him to purchase 10,332 shares at a price of $101.12 per share.
• These options vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remaining balance vesting in equal annual installments over the following three years.
• He also received 9,577 restricted stock units, which will vest over a four-year period.
• 25% of the restricted stock units will vest on the first anniversary of the grant date, with the remaining balance vesting in equal annual installments over the following three years.
• The restricted stock unit award includes a provision for the company to withhold shares to cover taxes due on each vesting date.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning management and shareholder interests. There are no negative implications.

Positives

• The grant of stock options and restricted stock units aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Risks

• The value of the stock options is dependent on the future performance of the company's stock price.
• The vesting of the restricted stock units could result in dilution of existing shareholders' equity.

Industry Context

Stock-based compensation is a common practice for publicly traded companies to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard compensation practices for CFOs in publicly traded companies.
• The vesting schedule of 25% on the first anniversary and the remainder over three years is a typical vesting schedule for these types of awards.
• Comparable companies in the medical device industry often use similar equity-based compensation packages to attract and retain talent.

Stakeholder Impact

• Shareholders may experience slight dilution due to the issuance of new shares upon vesting of the stock options and restricted stock units.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, vesting, Lemaitre Vascular Inc., LMAT, CFO, Joseph P. Pellegrino Jr.